HOME
- Breaking
- Photos
- Video
- Crime
- Obituaries
- Weather
- Traffic
- Crosswords
- Sudoku
- Horoscopes
- Apps
Local
- L.A. Now
- Politics
- Crime
- Education
- O.C.
- Westside
- Neighborhoods
- Environment
- Obituaries
- Data & Maps
U.S.
- Politics
- Nation Now
- Politics Now
- Top of the Ticket
- Science
- Science Now
- Obituaries
- Religion
World
- World Now
- Afghanistan war
- Africa
- Americas
- Asia
- Europe
- Middle East
Business
- Money & Co.
- Technology
- Highway 1
- Company Town
- Personal Finance
- Jobs
- Real Estate
- Cars
Sports
- Sports now
- Lakers
- Clippers
- Dodgers
- Angels
- NFL
- Kings
- NHL/Ducks
- USC
- UCLA
- Preps
- Scores
Entertainment
- Awards: The Envelope
- Movies
- TV
- Music
- Celebrity
- Arts & Culture
- Industry
- Critics' Picks
- Comics
Health
- Science Now
- Medicine
- Fitness & Nutrition
- Mental Health
- Health Reform
- Mind & Body
Living
- Home
- Food
- Image
- Books
- L.A. Affairs
- Comics
- Reader Photos
Travel
- SoCal
- California
- Mexico
- Hawaii
- Las Vegas
- Europe
- Asia
- Australia
- Travel & Deal Blog
Opinion
- Editorials
- Op-Ed
- Letters
- Opinion L.A.
- Readers' Rep
- Endorsements
Shop
- Daily Deals
- Travel Offers
- Coupons
- Weekly Circulars
- Offers & Deals
- Sports Gear
- LA Times Product
- See More
Membership Services
Jobs
Cars
Real Estate
Subscribe
Rentals
Weekly Circulars
Custom Publishing
Place Ad

Also. . .

NATION / WORLD

July 16, 1998

* Zonagen Inc. filed an application with the Food and Drug Administration for clearance to sell what would be the first challenger to Pfizer Inc.'s record-selling Viagra impotence pill. The pill, Vasomax, would be Zonagen's first drug on the market.

FEATURED

Skechers lawsuit: How to get your piece of the $40-million payout

Hard crash ends Danica Patrick's NASCAR race at Indianapolis

How to find your lost or stolen iPhone 5

MORE:

Top 10 cars: best gas mileage, lowest sticker price

Upsets abound in Farmers Classic quarterfinals as Ram, Berankis advance

|

|

|